source
- Novocure's electric field therapy fails Phase 3 glioblastoma trial, not extending patient survivalNovocure announced on Thursday that its electric fields device, used together with standard chemoradiation, did not improve overall survival for patients with glioblastoma in a Phase 3 trial. The…
- New poll shows only half of U.S. adults can afford quality health care, with record-high concerns for next yearA recent West Health-Gallup Affordability Index found that roughly 50% of American adults said they could pay for health care and still access quality services in the past year. The survey also re…